CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 115 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $21,670,000 | +54.9% | 191,596 | +37.1% | 0.30% | +46.6% |
Q1 2017 | $13,993,000 | -24.0% | 139,750 | -18.4% | 0.21% | -25.9% |
Q4 2016 | $18,416,000 | -21.4% | 171,280 | -9.0% | 0.28% | -20.3% |
Q3 2016 | $23,442,000 | +16.1% | 188,319 | -0.9% | 0.35% | +12.9% |
Q2 2016 | $20,197,000 | -7.4% | 189,963 | -0.6% | 0.31% | -7.2% |
Q1 2016 | $21,812,000 | -48.4% | 191,045 | -35.6% | 0.33% | -42.8% |
Q4 2015 | $42,250,000 | +44.9% | 296,573 | -8.7% | 0.58% | +49.2% |
Q3 2015 | $29,165,000 | – | 324,700 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |